UP-Pharma utilizes the latest bioanalytical equipment, such as HPLC and LC/MS/MS, under FDA and EMEA regulations. The focus of bioanalysis is to provide a quantitative measurement of the active drug and/or its metabolite(s) in various biological samples including those derived from cell culture media or from plasma, serum, CSF, urine, and tissue homogenates. We ensure high-quality, quick turn-around time and the lowest cost service.

    We specialize in:

• Pharmacokinetics: Profiles and modeling
• Bioanalysis: Quick method development, method validation, and sample analysis in GXP environment
• Pharmacodynamics: Biomarkers and clinical endpoints evaluation and validation.
• Toxicology: In vivo study management and conduction under GLP regulations
• Preclinical & Clinical Study Management